Skip to main content

BARCLAYS PLC

Position in MREO — Mereo BioPharma Group plc

CIK 312069 LONDON, X0

Position in MREO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$823
-$5,223 QoQ
Shares Held
2,496
-82.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MREO Over Time

Shares Held

Position Value (USD)

Derivatives in MREO

reported options exposure · as of Dec 31, 2025
CallValue
$2,335
CallShares
5,600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,173 across 455 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in MREO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $823 2,496
2025-12-31 $6,046 14,500
2025-12-31 $2,335 5,600
2025-09-30 $11,536 5,600
2024-09-30 $156 38
2024-06-30 $136 38
2024-03-31 $125 38
2023-12-31 $87 38
2023-09-30 $98 76
2023-06-30 $50 38
2023-03-31 $134,334 190,007
2022-12-31 $124,980 166,641
2022-09-30 $33,983 39,470
2022-06-30 $22,400 20,000
2022-03-31 $477,215 426,085
2021-12-31 $596,470 372,794
2021-09-30 $48,400 20,000
2021-06-30 $63,400 20,000
2021-03-31 $266,189 78,988